Skip to main content

Kristy Ainslie, PhD, is a UNC Lineberger Comprehensive Cancer Center member developing new immune-modulatory therapies that treat and prevent infectious and autoimmune diseases.

PhD
Fred Eshelman Distinguished Professor
Chair, Division Pharmacoengineering & Molecular Pharmaceutics
UNC-Chapel Hill
Molecular Therapeutics

Area of Interest

Kristy Ainslie, PhD, applies her knowledge base in biomaterials and immunology to develop new immune-modulatory therapies that treat and prevent infectious and autoimmune diseases.

Her lab aims to design practical and innovative formulations, taking into account the scalable production and applications in developing nations.

Find publications on ORCID

Headshot of Kristy Ainslie